Rheumatoid Arthritis

Physicians can use ultrasound technology to identify patients with rheumatoid arthritis (RA) who are in remission but could benefit from more intensive treatment.

Repetitive intraarticular corticosteroid injections to the temporomandibular joint do not prevent progressive osseous deformation nor normalize mandibular growth in children with juvenile idiopathic arthritis.

Recent studies have shown that measuring fatigue in rheumatoid arthritis and optimizing its treatment is becoming an increasingly important part of care

For the first time, it's been demonstrated that the proto-oncogene survivin can distinguish drug-specific clinical responses in early rheumatoid arthritis (RA), according to new study in BMC Medicine.

The European League Against Rheumatism and the American College of Rheumatology have published treatment recommendations for polymyalgia rheumatic, the most common inflammatory musculoskeletal disease of older people.

An increased risk of cardiovascular disease is present in early rheumatoid arthritis and early spondyloarthritis, new research shows.

A study in Arthritis Research & Therapy found that patients with rheumatoid arthritis (RA) experience shoulder pain early in the course of the disease, suggesting that screening of shoulder function should become a larger focus for maintenance and treatment of RA.

The field of rheumatology is largely the same whether it is in the civilian or military world. Differences can be seen in the cause of some of these conditions as well as the treatment options pursued by doctors.

The cells directly responsible for cartilage damage in rheumatoid arthritis might be a viable novel drug target for treatment.

Minor episodes of pain throughout the day can affect your mood and health outcomes.

Atypical femur fractures could be more common in rheumatoid arthritis patients with valgus knee alignment undergoing long-term treatment with bisphosphonates, study shows.

Abatacept performs well in rheumatoid arthritis patients who are positive for anti-citrullinated protein antibodies.

A study in BMC Musculoskeletal Disorders suggests that multinucleated giant cells (MGC) may contribute to osteoarthritis (OA) and rheumatoid arthritis (RA) in addition to their known association with synovitis severity. The finding adds to other recent research and points to the therapeutic potential of targeting MGCs to improve pain and joint damage in both types of arthritis.

Certolizumab pegol (CZP) + methotrexate (MTX) is safe and effective for patients with rheumatoid arthritis (RA) with disease activity despite methotrexate therapy, according to a five-year follow-up study published in Arthritis Research & Therapy. The finding is an extension of the Rheumatoid Arthritis Prevention of Structural Damage (RAPID 2) randomized, controlled trial. It is important because patients with RA are likely to undergo treatment with anti-tumor necrosis factor (anti-TNF) medications over several years.

Functional ability in early rheumatoid arthritis can be improved with intensive initial therapy with triple disease modifying anti-rheumatic disease (DMARD) drugs, according to results of a study presented at the European League Against Rheumatism Annual Congress in Rome, Italy in June.

Progress in RA research has stalled. "It is clear that the revolution is incomplete,” Lasker Award winners say.

A Phase III study comparing an infliximab biosimilar to Remicade for rheumatoid arthritis patients found that the two treatments have essentially the same outcomes.

Developing arthritis increases the risk of falling into poverty, especially for women, a new study shows.

Using an ultrasound to predict tenosynovitis may also predict early rheumatoid arthritis (RA), according to the results of a study presented at the European League Against Rheumatism Annual Congress (EULAR 2015) in Rome, Italy earlier this summer.

Evidence-based medicine and patient input needed in prescribing bisphosphonates for osteoporosis.

Patients with moderate rheumatoid arthritis (RA) taking disease-modifying anti-rheumatic drugs (DMARDs) have a similar risk of joint fracture that requires surgery as RA patients with high disease activity.

Distinguishing between different types of childhood arthritis is not always easy.

The use of steroid injections for low back pain is increasing, even though the evidence supporting it is declining.

Intensifying treatment during flare-ups outweighs concerns about over treatment.

Patient advocacy groups are praising the FDA for releasing a draft guidance for naming biosimilars.

Early diagnosis continues to be one of the biggest challenges associated with rheumatoid arthritis (RA); however, researchers have identified a genetic marker that can predict tissue damage severity that could lead to better treatments.

Study results suggest that longer exposure to methotrexate and other disease-modifying anti-rheumatic drugs within the first year of diagnosis is associated with a significantly longer time to joint replacement surgery.

Controlling depressive symptoms in patients with early inflammatory polyarthritis could affect disease outcomes, researchers suggest.

Study shows increased cardiovascular disease risk in RA. Screening and treatment recommended.

Patients with rheumatoid arthritis may do better with subcutaneous methotrexate compared with oral dosing, according to findings published in the Annals of the Rheumatic Diseases.